Drug intelligence / Profile preview

citalopram + zinc sulfate

Development stage
Preclinical
Lead developer
Lundbeck
Modality
Small Molecules
Administration
Oral
01

Overview

Citalopram + zinc sulfate is a non-standardized combination of two agents: citalopram, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and zinc sulfate, an inorganic salt used as a dietary supplement to provide elemental zinc. Citalopram acts by inhibiting the reuptake of serotonin in the central nervous system, thereby increasing serotonergic activity and improving symptoms of depression[5][6]. Zinc is an essential trace element involved in numerous enzymatic processes and has been studied for its potential role in modulating mood and supporting antidepressant efficacy. Clinical studies suggest that adjunctive zinc supplementation with SSRIs like citalopram may enhance reduction of depressive symptoms compared to SSRI therapy alone[3]. This combination does not represent a commercially available fixed-dose product but may be used off-label or as part of clinical research.

02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)DAT (Dopamine plasma membrane transport protein)SERT allosteric site (Serotonin transporter allosteric site)

Beyond the preview

Go deeper on citalopram + zinc sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citalopram + zinc sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call